Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Arcadia Biosciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 23 | 27 | +4 |
| Shares | 1.15M | 2.49M | +1.34M (+116.6%) |
| Value | $3.17M | $7.40M | +$4.23M (+133.5%) |
New holders (10)
Institutions that held Arcadia Biosciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ardsley Advisory Partners LP | 1,000,000 | $2.97M | 0.50% |
| MYDA Advisors LLC | 45,079 | $134.0K | 0.04% |
| State Street Corp | 36,300 | $108.0K | 0.00% |
| Goldman Sachs Group Inc | 31,666 | $94.0K | 0.00% |
| Jane Street Group, LLC | 19,525 | $58.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 15,500 | $46.0K | 0.00% |
| Two Sigma Securities, LLC | 10,917 | $32.0K | 0.01% |
| Pinz Capital Management, LP | 8,000 | $24.0K | 0.01% |
| Bedel Financial Consulting, Inc. | 1,845 | $5.00K | 0.00% |
| Bank of America Corp | 53 | $0 | 0.00% |
Sold out (6)
Institutions that held Arcadia Biosciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 135,505 | $373.0K |
| Millennium Management LLC | 88,960 | $245.0K |
| Moloney Securities Asset Management, LLC | 71,750 | $198.0K |
| Sabby Management, LLC | 67,136 | $185.0K |
| Bayesian Capital Management, LP | 36,100 | $99.0K |
| UBS Group AG | 9,249 | $25.0K |